LAWSUITS FILED AGAINST SRNE, KL and WRCDF - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
Back to Newsroom
Mentioned in this Article

LAWSUITS FILED AGAINST SRNE, KL and WRCDF - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS

Thursday, July 23, 2020 11:40 AM
Share this article now
Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / July 23, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Sorrento Therapeutics, Inc. (NASDAQ:SRNE)

CONTACT JAKUBOWITZ ABOUT SRNE:
https://claimyourloss.com/securities/sorrento-therapeutics-inc-loss-submission-form/?id=8138&from=1

Class Period: May 15, 2020 - May 22, 2020

Lead Plaintiff Deadline: July 27, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's initial finding of "100% inhibition" in an in vitro virus infection will not necessarily translate to success or safety in vivo, or in person; (ii) the Company's finding was not a "cure" for COVID-19; and (ii) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Kirkland Lake Gold Ltd. (NYSE:KL)

CONTACT JAKUBOWITZ ABOUT KL:
https://claimyourloss.com/securities/kirkland-lake-gold-ltd-loss-submission-form/?id=8138&from=1

Class Period: January 8, 2018 - November 25, 2019

Lead Plaintiff Deadline: August 28, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Kirkland lacked adequate internal controls over financial reporting, especially as it relates to its projections of risks, reserve grade, and all-in sustaining costs; (ii) as a result of the known, but undisclosed, impending acquisition of Detour, the Company's projections relating to its risks, reserve grade, and all-in sustaining costs were false and misleading; (iii) the Company's financial statements and projections were not fairly presented in conformity with International Financial Reporting Standards; (iv) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company's business, operations, and prospects and/or lacked a reasonable basis and omitted material facts.

Wirecard AG (OTCPINK:WRCDF)

CONTACT JAKUBOWITZ ABOUT WRCDF:
https://claimyourloss.com/securities/wirecard-ag-loss-submission-form/?id=8138&from=1

Class Period: August 17, 2015 - June 24, 2020

Lead Plaintiff Deadline: September 8, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Wirecard overstated its cash balances during the Class Period, falsely claiming €1.9 billion of cash in a trust account that was missing; (2) Wirecard overstated its financial results during the Class Period, including revenue and EBITDA; (3) Wirecard did not have adequate risk management or countermeasures; (4) the Company's external auditor failed to audit Wirecard in accordance with applicable auditing principles; and (5) as a result, Defendants' statements about Wirecard's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law

Jakubowitz Law
Back to Newsroom
Copyright 2020 © ACCESSWIRE. All rights reserved. Privacy Policy  |  Terms and Conditions
Drop us a line: